Suchergebnisse - "Selinger, Christian"

PubPharm (280)

41

Systematic review with network meta‐analysis : Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Din, S. | Selinger, C. | Black, C. | +1

42

Does exposure to different menstrual products affect the vaginal environment?

enthalten in: Molecular Ecology | 2023

von Tessandier, N. | Uysal, I. | Elie, B. | +22

43

Predicting COVID-19 incidence in French hospitals using human contact network analytics

enthalten in: bioRxiv.org | 2023

von Selinger, C. | Choisy, M. | Alizon, S.

44

The development of a minimum dataset for MRI reporting of anorectal fistula : a multi-disciplinary, expert consensus process

enthalten in: European radiology | 2022

von Iqbal, N. | Sackitey, C. | Gupta, A. | +13

45

Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection

enthalten in: bioRxiv.org | 2022

von Selinger, C. | Rahmoun, M. | Murall, C. | +10

46

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

47

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

48

Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients

enthalten in: Digestive diseases and sciences | 2022

von Gebeyehu, G. | Fiske, J. | Liu, E. | +7

49

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease : results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Chanchlani, N. | Lin, S. | Auth, M. | +99

CommentIn: Aliment Pharmacol Ther. 2022 Oct;56(8):1294-1295. - PMID 36168263

50

Live vaccinations for infants exposed to maternal infliximab in utero and via breast milk - the need for nuanced decision making

enthalten in: BMJ open gastroenterology | 2022

von Selinger, C. | Bel Kok, K. | Limdi, J. | +3